True cost of sharps injuries ignored, say German clinics
This article was originally published in Clinica
Better sharps injury avoidance provisions in German hospitals would spare potentially serious infections of medical personnel and save the associated costs, whose true level is not known but is estimated at over E10m ($12.7m) for the half a million professional injuries of this type that happen every year.
You may also be interested in...
ConMed's CFO Todd Garner told delegates at the Jefferies Healthcare conference that the company's orthopedic franchise is focused on its pipeline and meeting customer's needs. See what the CFO said about it here.
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.